135 related articles for article (PubMed ID: 28982847)
1. The Role of Toll Like Receptors (TLRs) in Oral Carcinogenesis.
Pisani LP; Estadella D; Ribeiro DA
Anticancer Res; 2017 Oct; 37(10):5389-5394. PubMed ID: 28982847
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
Li TT; Ogino S; Qian ZR
World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
[TBL] [Abstract][Full Text] [Related]
3. Activation of TLR2 and TLR5 did not affect tumor progression of an oral squamous cell carcinoma, YD-10B cells.
Park JH; Yoon HE; Jeon DI; Ahn SG; Yoon JH
J Oral Pathol Med; 2010 Nov; 39(10):781-5. PubMed ID: 20456615
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
[TBL] [Abstract][Full Text] [Related]
5. Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target.
Santoni M; Andrikou K; Sotte V; Bittoni A; Lanese A; Pellei C; Piva F; Conti A; Nabissi M; Santoni G; Cascinu S
Cancer Treat Rev; 2015 Jul; 41(7):569-76. PubMed ID: 26036357
[TBL] [Abstract][Full Text] [Related]
6. Decreased functional response to Toll like receptor ligands in patients with oral cancer.
Paleja B; Anand A; Chaukar D; D'Cruz A; Chiplunkar S
Hum Immunol; 2013 Aug; 74(8):927-36. PubMed ID: 23628388
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptors: cost or benefit for cancer?
Matijevic T; Pavelic J
Curr Pharm Des; 2010; 16(9):1081-90. PubMed ID: 20030618
[TBL] [Abstract][Full Text] [Related]
8. Intervention on toll-like receptors in pancreatic cancer.
Vaz J; Andersson R
World J Gastroenterol; 2014 May; 20(19):5808-17. PubMed ID: 24914341
[TBL] [Abstract][Full Text] [Related]
9. Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis.
Mishra BB; Mishra PK; Teale JM
J Neuroimmunol; 2006 Dec; 181(1-2):46-56. PubMed ID: 17011049
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation.
Fonte E; Agathangelidis A; Reverberi D; Ntoufa S; Scarfò L; Ranghetti P; Cutrona G; Tedeschi A; Xochelli A; Caligaris-Cappio F; Ponzoni M; Belessi C; Davis Z; Piris MA; Oscier D; Ghia P; Stamatopoulos K; Muzio M
Haematologica; 2015 Nov; 100(11):1460-8. PubMed ID: 26294727
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptors as interferon-regulated genes and their role in disease.
Khoo JJ; Forster S; Mansell A
J Interferon Cytokine Res; 2011 Jan; 31(1):13-25. PubMed ID: 21198355
[TBL] [Abstract][Full Text] [Related]
12. Antidepressants normalize elevated Toll-like receptor profile in major depressive disorder.
Hung YY; Huang KW; Kang HY; Huang GY; Huang TL
Psychopharmacology (Berl); 2016 May; 233(9):1707-14. PubMed ID: 26415953
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.
Howell J; Sawhney R; Testro A; Skinner N; Gow P; Angus P; Ratnam D; Visvanathan K
Liver Transpl; 2013 Oct; 19(10):1099-107. PubMed ID: 23894100
[TBL] [Abstract][Full Text] [Related]
14. Role of toll-like receptors in tissue repair and tumorigenesis.
Rakoff-Nahoum S; Medzhitov R
Biochemistry (Mosc); 2008 May; 73(5):555-61. PubMed ID: 18605980
[TBL] [Abstract][Full Text] [Related]
15. Decreased Toll-interacting protein and peroxisome proliferator-activated receptor γ are associated with increased expression of Toll-like receptors in colon carcinogenesis.
Pimentel-Nunes P; Gonçalves N; Boal-Carvalho I; Afonso L; Lopes P; Roncon-Albuquerque R; Soares JB; Cardoso E; Henrique R; Moreira-Dias L; Dinis-Ribeiro M; Leite-Moreira AF
J Clin Pathol; 2012 Apr; 65(4):302-8. PubMed ID: 22228906
[TBL] [Abstract][Full Text] [Related]
16. Role of toll-like receptors in cervical, endometrial and ovarian cancers: a review.
Husseinzadeh N; Davenport SM
Gynecol Oncol; 2014 Nov; 135(2):359-63. PubMed ID: 25135000
[TBL] [Abstract][Full Text] [Related]
17. Role of Toll like receptor in progression and suppression of oral squamous cell carcinoma.
Sharma Y; Bala K
Oncol Rev; 2020 Feb; 14(1):456. PubMed ID: 32477468
[TBL] [Abstract][Full Text] [Related]
18. Roles of Toll-Like Receptors in Radiotherapy- and Chemotherapy-Induced Oral Mucositis: A Concise Review.
Ji L; Hao S; Wang J; Zou J; Wang Y
Front Cell Infect Microbiol; 2022; 12():831387. PubMed ID: 35719331
[TBL] [Abstract][Full Text] [Related]
19. Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?
O'Neill LA
Nat Clin Pract Rheumatol; 2008 Jun; 4(6):319-27. PubMed ID: 18446139
[TBL] [Abstract][Full Text] [Related]
20. Hypertonic saline enhances host defense to bacterial challenge by augmenting Toll-like receptors.
Chen LW; Huang HL; Lee IT; Hsu CM; Lu PJ
Crit Care Med; 2006 Jun; 34(6):1758-68. PubMed ID: 16625117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
